Frank Moffatt
2 SlideShares 24 Followers 223 Folgens
Personal Information
Unternehmen/Arbeitsplatz
Basel Area, Switzerland Switzerland
Beruf
Director of Business Development at NovAliX
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.linkedin.com/in/fmoffatt
Info
1) Globally networked in the pharma & fine chemicals 2) Highly focused but change oriented 3) High growth sales producer for pharmaceutical services GOAL: To make significant long-term contributions within a globally competitive organisation. SPECIALITIES: Sales, business development, marketing, innovation, R&D, pharmaceutical services, drug discovery, process chemistry, biopharmaceuticals & biosimilars
Kontaktdetails
Tags
drug discovery chemical synthesis fragment based drug discovery affinity purification novel affinity ligands enzyme purification downstream processing biosimilars protein a graffinity purification of proteins biologics biobetters
Mehr anzeigen

Präsentationen

(2)

Graffinity: Novel affinity ligands for downstream processing of proteins

Vor 10 Jahren • 2085 Aufrufe

Introduction to NovAliX

Vor 10 Jahren • 2026 Aufrufe

Gefällt mir

(3)

Zartler chi fbdd_apr2013

Edward Zartler • Vor 8 Jahren

Biogenerics – Evolving Risks and Opportunities_M Staples_Mar08

m_a_staples • Vor 15 Jahren

Future trends and perspectives in modern pharmaceutical biotechnology

inemet • Vor 16 Jahren
Personal Information
Unternehmen/Arbeitsplatz
Basel Area, Switzerland Switzerland
Beruf
Director of Business Development at NovAliX
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.linkedin.com/in/fmoffatt
Info
1) Globally networked in the pharma & fine chemicals 2) Highly focused but change oriented 3) High growth sales producer for pharmaceutical services GOAL: To make significant long-term contributions within a globally competitive organisation. SPECIALITIES: Sales, business development, marketing, innovation, R&D, pharmaceutical services, drug discovery, process chemistry, biopharmaceuticals & biosimilars
Tags
drug discovery chemical synthesis fragment based drug discovery affinity purification novel affinity ligands enzyme purification downstream processing biosimilars protein a graffinity purification of proteins biologics biobetters
Mehr anzeigen